Anxiety Over Radiation Drives a Sales Surge for a Drug Against Thyroid Cancer


March 16, 2011

The New York Times

As Japan races to avoid a nuclear disaster, some Americans and companies in the United States are scrambling to obtain potassium iodide, a drug that can protect people from radiation-induced thyroid cancer.

“We’ve sold more in the past three days than we have in the past three years,” said Jim Small, president of the American arm of Recipharm, a Swedish company that is a major supplier of potassium iodide... Read More